Glioma is the most common
brain tumor. C6 rat
glioblastoma cells provide the possibility to the scientist to study
brain cancer.
Concanavalin A (Con A) has a lot of antitumoral effects, especially over oxidative stress. In the present study, it was aimed to decide the impacts of various doses of Con A on C6
glioblastoma cells regarding cytotoxicity,
thiol/
disulfide homeostasis, apoptosis, and
inflammation. We detected the cytotoxic activity of Con A (from 7.8 to 500 µg/ml) in C6 cells by utilizing
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and determined the toxic concentration of Con A. Once the optimal doses were found, the
thiol-
disulfide homeostasis, levels of total
antioxidant and
oxidant status (TAS and TOS),
malondialdehyde (MDA) and
glutathione (GSH), pro-inflammatory
cytokines as
tumor necrosis factor-alpha (TNF-α) and
interleukin-6 (IL-6), apoptotic
proteins as
cytochrome c (CYCS), and
caspase 3 (
CASP3) were measured. Apoptotic and morphological changes in the C6 cells were examined with an inverted microscope and flow cytometry technique. Dose-dependent Con A triggered oxidative damage in the C6 cells, affecting the inflammatory pathway, so reducing proliferation with apoptotic
proteins and morphological changes. But especially, Con A increased
disulfide formation by disrupting the
thiol/
disulfide balance in C6 cells. This study revealed that Con A, known as
carbohydrate-binding protein, generated oxidative damage,
inflammation, and apoptosis in a dose-dependent manner by modulating
thiol/
disulfide homeostasis in C6
glioblastoma cells.